Description
EMGLYZA 25mg tablets provide an advanced level of treatment for adults with type 2 diabetes. Each tablet contains 25mg of Empagliflozin, an SGLT2 inhibitor that works by prompting the kidneys to excrete excess glucose from the body through urine, thereby effectively lowering blood sugar levels. This higher strength is often prescribed when a more potent glycemic control is needed. In addition to its blood sugar-lowering effects, EMGLYZA 25mg is also indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and progression of chronic kidney disease in relevant adult patients. Taken once daily, with or without food, it serves as a crucial component of a comprehensive diabetes management plan, alongside diet and exercise. Consult your doctor for appropriate dosage and use.
